Intra-Cellular Therapies, Inc. Company Information
Intra-Cellular Therapies, Inc.'s employee growth, exchange listings and data sources
Key Information
- Name: Intra-Cellular Therapies, Inc.
- Ticker: 23I
- Exchange: DB
- Founded: 2002
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: US$9.080b
- Listing Market Cap: US$8.581b
- Shares Outstanding: 106.02m
- Website: https://www.intracellulartherapies.com
Number of Employees
Location
- Intra-Cellular Therapies, Inc.
- 430 East 29th Street
- New York
- New York
- 10016
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| ITCI | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | Dec 2013 |
| 23I | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Dec 2013 |
| ITCI * | BMV (Bolsa Mexicana de Valores) | Yes | Common Stock | MX | MXN | Dec 2013 |
| I2TC34 | BOVESPA (Bolsa de Valores de Sao Paulo) | BDR EACH 6 REPR 1 COM | BR | BRL | Jul 2023 |
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/11/29 00:29 |
| End of Day Share Price | 2024/11/29 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.